touchOPHTHALMOLOGY touchOPHTHALMOLOGY
Start activity
 
Focus Questions
What assessments are done prior to cataract surgery to aid IOL power calculation?
What assessments are done prior to cataract surgery to aid IOL power calculation?
How do ‘atypical’ ocular characteristics or prior refractive surgery impact IOL power calculation?
How do ‘atypical’ ocular characteristics or prior refractive surgery impact IOL power calculation?
How do ocular comorbidities affect preoperative workup and management?
How do ocular comorbidities affect preoperative workup and management?
What are the traditional, established formulas for calculating IOL power and what challenges are associated with these?
What are the traditional, established formulas for calculating IOL power and what challenges are associated with these?
How can AI help to address the challenges associated with IOL power calculation?
How can AI help to address the challenges associated with IOL power calculation?
How has AI been used to develop new IOL power calculation formulas?
How has AI been used to develop new IOL power calculation formulas?
How do AI-based approaches compare with each other and with traditional, established methods of IOL power calculation?
How do AI-based approaches compare with each other and with traditional, established methods of IOL power calculation?
What are the key developments and innovations in IOL technology from 2024?
What are the key developments and innovations in IOL technology from 2024?
How might emerging and future IOL technologies address the current unmet needs?
How might emerging and future IOL technologies address the current unmet needs?
Take CE/CME Test
Cataract Surgery, Refractive Surgery CE/CME accredited

touchFOCUS
Quickfire Q&A with expert faculty. Close

Advances in IOL technology and power calculations: Updates and innovations from 2024

Take CE/CME Test

Dr John Ladas is a board-certified/fellowship-trained surgeon specializing in cataract surgery. He practises in Silver Spring, MD, USA. read more

He received his MD and PhD from the Georgetown University School of Medicine, Washington, DC, USA, and was elected to the Alpha Omega Alpha National Medical Honor Society. He completed his ophthalmology training at the UCLA-Jules Stein Eye Institute, CA, USA, and the Johns Hopkins/Wilmer Eye Institute, MD, USA, where he was awarded the Heed Fellowship. He is a member of the American Academy of Ophthalmology, American Society of Cataract and Refractive Surgery and the Society of Heed Fellows.

Dr Ladas’s specific research interests involve the mathematical formulas involved in calculating the lens power at the time of surgery and their ongoing improvement with artificial intelligence. His proprietary formula, the Ladas Super Formula (LSF), has been shown to be one of the most accurate and is available online worldwide. It is the first and only IOL calculation formula to be granted a US Patent. Dr Ladas has authored multiple publications and has given invited lectures worldwide regarding this subject. In the November 2021 Anniversary issue of Ophthalmology Management, Dr Ladas was honoured as one of the top 25 leaders in innovation over the past 25 years in ophthalmology for his contributions.

Dr John Ladas discloses: Stock/shareholder (self-managed) from Advanced Euclidean Solutions.

Learning Objectives

After watching this activity, participants should be better able to:

  • Identify appropriate IOL power calculations, including AI-based tools, for preoperative assessment and after refractive surgery
  • Describe new advancements in IOL technology for patients with cataracts
Overview

In this interview, Dr John Ladas answers a series of questions on intraocular lens (IOL) power calculation, including how the use of artificial intelligence may help to improve accuracy, as well as providing an update on key advances in IOL technology.

This activity is funded by an independent medical education grant from Johnson & Johnson Surgical Vision, Inc. and Carl Zeiss Meditec, Inc. read more

Target Audience

Ophthalmologists, with a focus on cataract and refractive surgeons involved in the management of patients with cataract.

Disclosures

USF Health adheres to the Standards for Integrity and Independence in Accredited Continuing Education. All individuals in a position to influence content have disclosed to USF Health any financial relationship with an ineligible organization. USF Health has reviewed and mitigated all relevant financial relationships related to the content of the activity. The relevant relationships are listed below. All individuals not listed have no relevant financial relationships.

Faculty

Dr John Ladas discloses: Stock/shareholder (self-managed) from Advanced Euclidean Solutions.

Content Reviewer

Thomas Weppelmann, MD, PhD, MPH has no financial interests/relationships or affiliations in relation to this activity.

Touch Medical Contributors

Kathy Day has no financial interests/relationships or affiliations in relation to this activity.

USF Health Office of Continuing Professional Development and touchIME staff have no financial interests/relationships or affiliations in relation to this activity.

Requirements for Successful Completion

In order to receive credit for this activity, participants must review the content and complete the post-test and evaluation form. Statements of credit are awarded upon successful completion of the post-test and evaluation form.

If you have questions regarding credit please contact cpdsupport@usf.edu.

Accreditations

Physicians

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through a joint providership of USF Health and touchIME. USF Health is accredited by the ACCME to provide continuing medical education for physicians.

USF Health designates this enduring material for a maximum of 0.5 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The European Union of Medical Specialists (UEMS) – European Accreditation Council for Continuing Medical Education (EACCME) has an agreement of mutual recognition of continuing medical education (CME) credit with the American Medical Association (AMA). European physicians interested in converting AMA PRA Category 1 CreditTM into European CME credit (ECMEC) should contact the UEMS (www.uems.eu).

Advanced Practice Providers

Physician Assistants may claim a maximum of 0.5 Category 1 credits for completing this activity. NCCPA accepts AMA PRA Category 1 CreditTM from organizations accredited by ACCME or a recognized state medical society.

The AANPCP accepts certificates of participation for educational activities approved for AMA PRA Category 1 CreditTM by ACCME-accredited providers. APRNs who participate will receive a certificate of completion commensurate with the extent of their participation.

Date of original release: 5 December 2024. Date credits expire: 5 December 2027.

If you have any questions regarding credit please contact cpdsupport@usf.edu.

This activity is CE/CME accredited

To obtain the CE/CME credit(s) from this activity, please complete this post-activity test.

Claim Credit

Topics covered in this activity

Cataract Surgery / Refractive Surgery
REGISTER NOW FOR FREE ACCESS TO
  • 1000+ topical and insightful peer-reviewed journal articles
  • 100+ hours of bite-sized congress highlights
  • 10 major therapy areas packed with the latest scientific advances
  • 150+ specialties offering learn-on-the-go medical education
  • + Concise email updates and newsletters so you never miss out
Register For Free Now
Claim Credit
touchFOCUS
Advances in IOL technology and power calculations: Updates and innovations from 2024
0.5 CE/CME credit

Question 1/5
In addition to biometry and keratometry, how can wavefront aberrometry assist with accurate IOL power calculation prior to cataract surgery?

IOL, intraocular lens.

To achieve the desired refraction after cataract surgery, the required power of the IOL implant can be calculated from optical biometry measurements.1 These measurements primarily include axial length, corneal refractive power (keratometry) and media type,1 but current biometry devices can also measure anterior chamber depth; white-to-white distance; thickness of the central cornea, retina and lens; and pupil diameter, among others.2 Wavefront aberrometry is an objective method of measuring refractive power, based on the way a light beam moves through the eye.3 It can be used in the diagnosis of both higher-order errors, such as complex visual defects that can cause halos, ghost images and other visual symptoms, as well as lower-order errors, such as nearsightedness, farsightedness and astigmatism, which conventional methods of eye examination are unable to detect.3

Abbreviation

IOL, intraocular lens.

References

  1. Shahzad HSF. 2024. Available at: https://eyewiki.org/Biometry_for_Intra-Ocular_Lens_(IOL)_Power_Calculation (accessed 12 November 2024).
  2. Pathak M, et al. Clin Ophthalmol. 2024;18:1191–206.
  3. Vessel M. 2019. Available at: www.allaboutvision.com/eye-exam/wavefront.htm (accessed 7 November 2024).
Question 2/5
A 76-year-old patient with stable neovascular AMD has been referred to you for cataract surgery. How would you approach this case to ensure an accurate IOL calculation?

AMD, age-related macular degeneration; IOL, intraocular lens.

Cataract surgery in patients with AMD can improve visual function and quality of life across all severity grades of AMD, at least in the short-term.1,2 The same principles of IOL measurement used for patients undergoing routine cataract surgery apply to those with retinal pathology.3 However, certain ocular conditions, such as macular degeneration, strabismus and opaque media, can cause poor fixation,4 and one disadvantage of optical biometry, compared with ultrasound biometry, is that measurements are not possible in patients who are unable to fixate eyes.5

Abbreviations

AMD, age-related macular degeneration; IOL, intraocular lens.

References

  1. Miller KM, et al. Ophthalmology. 2022;129:P1–126.
  2. ESCRS. 2024. Available at: www.escrs.org/escrs-guideline-for-cataract-surgery/ (accessed 13 November 2024).
  3. Weng CY, Weikert MP. CSRT. 2020. Available at: https://crstoday.com/articles/2020-nov-dec/iol-selection-for-retina-patients (accessed 13 November 2024).
  4. Chen SH, Luo ZK. eye Insights 16. Available at: https://eye.hms.harvard.edu/book/preoperative-preparation-optical-biometry (accessed 13 November 2024).
  5. Pathak M, et al. Clin Ophthalmol. 2024;18:1191–206.
Question 3/5
What is a key benefit of using AI to assist with IOL power calculation?

AI, artificial intelligence; IOL, intraocular lens.

Even new-generation IOL power calculators, with effective lens position determination and increased input parameters, remain limited because the parameters are fixed in terms of quantity and type.sup>1Modern formulas that leverage machine learning (AI formulas) are theoretically more accurate because they are created using large datasets that take into account multiple variables, they use advanced machine learning algorithms for creating predictive models, and can be cloud-based and updated in perpetuity as postoperative refractive data become available.1This continuous improvement allows AI-based calculators to evolve dynamically over time.1,2

Abbreviations

AI, artificial intelligence; IOL, intraocular lens.

References

  1. de Rojas J, Ladas J. CRST. June 2023. Available at: https://crstoday.com/articles/june-2023/ai-models-for-iol-calculation(accessed 12 November 2024).
  2. Siddiqui AA, Ladas JG. Ophthalmol Manag. April 2019. Available at: https://ophthalmologymanagement.com/issues/2018/april/using-ai-in-iol-calculations/ (accessed 14 November 2024).
Question 4/5
In a preoperative consultation for cataract surgery, your patient mentions having heard about the TECNIS Odyssey IOL and asks for more information. Which of the following statements would you include in your answer?

IOL, intraocular lens.

Data for the TECNIS Odyssey IOL were presented at ASCRS 2024.1,2An ambispective clinical trial showed that, in the four bilaterally implanted patients with 1- and 3-month postoperative data, mean manifest refraction spherical equivalent was 0.12 D with mean binocular logMAR (Snellen) uncorrected distant VA of -0.12 (20/15), mean distance corrected intermediate VA at 66 cm was 0.08 (20/24) and depth of focus was 0.18 (20/30) or better between +0.5 D to -3.0 D; three patients demonstrated complete spectacle independence.1 In a real-world study of 96 patients bilaterally implanted with the TECNIS Odyssey IOL, mean binocular logMAR (Snellen) uncorrected distant VA was 0.01 (20/20), best corrected distance VA was -0.03 (20/20), and uncorrected near VA at 40 cm was 0.10 (J1 equivalent).2 No subjects reported experiencing starbursts, 85% of patients reported no or mild halo, and 89% reported no or mild night glare; 96.4% (80/83) did not require spectacle correction for distance, intermediate or near vision at the 1-month visit.2

Abbreviations

ASCRS, American Society of Cataract and Refractive Surgery; IOL, intraocular lens; logMAR, logarithm of the minimum angle of resolution; VA, visual acuity.

References

  1. Waring GO, et al. Presented at: ASCRS, Boston, MA, USA. 5–8 April 2024. Abstr 50686.
  2. Mathews PM, et al. Presented at: ASCRS, Boston, MA, USA. 5–8 April 2024. Abstr 50685.
Question 5/5
Your 71-year-old patient, who had myopic LASIK 5 years ago, now needs cataract surgery. The patient has no retinal or corneal surface pathology but has regular astigmatism (+2 D) and a desire for spectacle independence following surgery. Assuming all options are available to you, which IOL would you select for this patient?

EDOF, extended depth of focus; IOL, intraocular lens.

Patients with a history of laser refractive surgery have an altered anterior and posterior corneal surface relationship, which can make preoperative biometry, IOL calculations and postoperative refractive error challenging, mainly through altered predictability of effective lens position following cataract surgery. The light adjustable lens is designed such that the power can be adjusted to correct both residual spherical and cylindrical refractive errors postoperatively through a noninvasive procedure using a spatially profiled ultraviolet light beam in the weeks following IOL implantation and refractive stabilization. Given that the light adjustable lens can be fine-tuned to neutralize refractive error following cataract surgery, it provides a refractive advantage in the post-refractive surgery patient population by mitigating the effects of refractive surprise.

Abbreviation

IOL, intraocular lens.

Reference

Wong JR, et al. Clin Ophthalmol. 2023;17:3379–87.

Back to Activity
Copied to clipboard!
accredited arrow-down-editablearrow-downarrow_leftarrow-right-bluearrow-right-dark-bluearrow-right-greenarrow-right-greyarrow-right-orangearrow-right-whitearrow-right-bluearrow-up-orangeavatarcalendarchevron-down consultant-pathologist-nurseconsultant-pathologistcrosscrossdownloademailexclaimationfeedbackfiltergraph-arrowinterviewslinkmdt_iconmenumore_dots nurse-consultantpadlock patient-advocate-pathologistpatient-consultantpatientperson pharmacist-nurseplay_buttonplay-colour-tmcplay-colourAsset 1podcastprinter scenerysearch share single-doctor social_facebooksocial_googleplussocial_instagramsocial_linkedin_altsocial_linkedin_altsocial_pinterestlogo-twitter-glyph-32social_youtubeshape-star (1)tick-bluetick-orangetick-red tick-whiteticktimetranscriptup-arrowwebinar Sponsored Department Location NEW TMM Corporate Services Icons-07NEW TMM Corporate Services Icons-08NEW TMM Corporate Services Icons-09NEW TMM Corporate Services Icons-10NEW TMM Corporate Services Icons-11NEW TMM Corporate Services Icons-12Salary £ TMM-Corp-Site-Icons-01TMM-Corp-Site-Icons-02TMM-Corp-Site-Icons-03TMM-Corp-Site-Icons-04TMM-Corp-Site-Icons-05TMM-Corp-Site-Icons-06TMM-Corp-Site-Icons-07TMM-Corp-Site-Icons-08TMM-Corp-Site-Icons-09TMM-Corp-Site-Icons-10TMM-Corp-Site-Icons-11TMM-Corp-Site-Icons-12TMM-Corp-Site-Icons-13TMM-Corp-Site-Icons-14TMM-Corp-Site-Icons-15TMM-Corp-Site-Icons-16TMM-Corp-Site-Icons-17TMM-Corp-Site-Icons-18TMM-Corp-Site-Icons-19TMM-Corp-Site-Icons-20TMM-Corp-Site-Icons-21TMM-Corp-Site-Icons-22TMM-Corp-Site-Icons-23TMM-Corp-Site-Icons-24TMM-Corp-Site-Icons-25TMM-Corp-Site-Icons-26TMM-Corp-Site-Icons-27TMM-Corp-Site-Icons-28TMM-Corp-Site-Icons-29TMM-Corp-Site-Icons-30TMM-Corp-Site-Icons-31TMM-Corp-Site-Icons-32TMM-Corp-Site-Icons-33TMM-Corp-Site-Icons-34TMM-Corp-Site-Icons-35TMM-Corp-Site-Icons-36TMM-Corp-Site-Icons-37TMM-Corp-Site-Icons-38TMM-Corp-Site-Icons-39TMM-Corp-Site-Icons-40TMM-Corp-Site-Icons-41TMM-Corp-Site-Icons-42TMM-Corp-Site-Icons-43TMM-Corp-Site-Icons-44TMM-Corp-Site-Icons-45TMM-Corp-Site-Icons-46TMM-Corp-Site-Icons-47TMM-Corp-Site-Icons-48TMM-Corp-Site-Icons-49TMM-Corp-Site-Icons-50TMM-Corp-Site-Icons-51TMM-Corp-Site-Icons-52TMM-Corp-Site-Icons-53TMM-Corp-Site-Icons-54TMM-Corp-Site-Icons-55TMM-Corp-Site-Icons-56TMM-Corp-Site-Icons-57TMM-Corp-Site-Icons-58TMM-Corp-Site-Icons-59TMM-Corp-Site-Icons-60TMM-Corp-Site-Icons-61TMM-Corp-Site-Icons-62TMM-Corp-Site-Icons-63TMM-Corp-Site-Icons-64TMM-Corp-Site-Icons-65TMM-Corp-Site-Icons-66TMM-Corp-Site-Icons-67TMM-Corp-Site-Icons-68TMM-Corp-Site-Icons-69TMM-Corp-Site-Icons-70TMM-Corp-Site-Icons-71TMM-Corp-Site-Icons-72
Close Popup